SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-014821
Filing Date
2023-03-30
Accepted
2023-03-30 16:12:42
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A brhc10050607_defa14a.htm DEFA14A 30148
2 EXHIBIT 2.1 brhc10050607_ex2-1.htm EX-2.1 95873
3 EXHIBIT 2.2 brhc10050607_ex2-2.htm EX-2.2 61769
4 EXHIBIT 2.3 brhc10050607_ex2-3.htm EX-2.3 19519
  Complete submission text file 0001140361-23-014821.txt   208352
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-51173 | Film No.: 23780829
SIC: 2834 Pharmaceutical Preparations